Sun Pharma to invest ₹500 crore in Assam for new manufacturing unit; shares rise 1%
Sun Pharmaceutical Industries Ltd. announced a ₹500 crore investment in Assam on February 5, 2026. This initiative marked a major step in expanding its manufacturing footprint in India. The project involves setting up a new pharmaceutical manufacturing unit, expected to create over 500 direct jobs in the region.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
